Cargando…

The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)

Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hajj, H. I., Vluggens, A., Andreoletti, P., Ragot, K., Mandard, S., Kersten, S., Waterham, H. R., Lizard, G., Wanders, R. J. A., Reddy, J. K., Cherkaoui-Malki, Mustapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791418/
https://www.ncbi.nlm.nih.gov/pubmed/22508517
http://dx.doi.org/10.1210/en.2012-1137
_version_ 1782286717949050880
author El Hajj, H. I.
Vluggens, A.
Andreoletti, P.
Ragot, K.
Mandard, S.
Kersten, S.
Waterham, H. R.
Lizard, G.
Wanders, R. J. A.
Reddy, J. K.
Cherkaoui-Malki, Mustapha
author_facet El Hajj, H. I.
Vluggens, A.
Andreoletti, P.
Ragot, K.
Mandard, S.
Kersten, S.
Waterham, H. R.
Lizard, G.
Wanders, R. J. A.
Reddy, J. K.
Cherkaoui-Malki, Mustapha
author_sort El Hajj, H. I.
collection PubMed
description Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components of this inflammatory process in P-NALD remain elusive. In this study, we used transcriptomic profiling and PCR array analyses to explore inflammatory gene expression in patient fibroblasts. Our results show the activation of IL-1 inflammatory pathway accompanied by the increased secretion of two IL-1 target genes, IL-6 and IL-8 cytokines. Human fibroblasts exposed to very-long-chain fatty acids exhibited increased mRNA expression of IL-1α and IL-1β cytokines. Furthermore, expression of IL-6 and IL-8 cytokines in patient fibroblasts was down-regulated by MAPK, p38MAPK, and Jun N-terminal kinase inhibitors. Thus, the absence of acyl-coenzyme A oxidase 1 activity in P-NALD fibroblasts triggers an inflammatory process, in which the IL-1 pathway seems to be central. The use of specific kinase inhibitors may permit the modulation of the enhanced inflammatory status.
format Online
Article
Text
id pubmed-3791418
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-37914182013-11-01 The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy) El Hajj, H. I. Vluggens, A. Andreoletti, P. Ragot, K. Mandard, S. Kersten, S. Waterham, H. R. Lizard, G. Wanders, R. J. A. Reddy, J. K. Cherkaoui-Malki, Mustapha Endocrinology Brief Reports Among several peroxisomal neurodegenerative disorders, the pseudoneonatal adrenoleukodystrophy (P-NALD) is characterized by the acyl-coenzyme A oxidase 1 (ACOX1) deficiency, which leads to the accumulation of very-long-chain fatty acids (VLCFA) and inflammatory demyelination. However, the components of this inflammatory process in P-NALD remain elusive. In this study, we used transcriptomic profiling and PCR array analyses to explore inflammatory gene expression in patient fibroblasts. Our results show the activation of IL-1 inflammatory pathway accompanied by the increased secretion of two IL-1 target genes, IL-6 and IL-8 cytokines. Human fibroblasts exposed to very-long-chain fatty acids exhibited increased mRNA expression of IL-1α and IL-1β cytokines. Furthermore, expression of IL-6 and IL-8 cytokines in patient fibroblasts was down-regulated by MAPK, p38MAPK, and Jun N-terminal kinase inhibitors. Thus, the absence of acyl-coenzyme A oxidase 1 activity in P-NALD fibroblasts triggers an inflammatory process, in which the IL-1 pathway seems to be central. The use of specific kinase inhibitors may permit the modulation of the enhanced inflammatory status. Endocrine Society 2012-06 2012-04-16 /pmc/articles/PMC3791418/ /pubmed/22508517 http://dx.doi.org/10.1210/en.2012-1137 Text en Copyright © 2012 by The Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/us/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
El Hajj, H. I.
Vluggens, A.
Andreoletti, P.
Ragot, K.
Mandard, S.
Kersten, S.
Waterham, H. R.
Lizard, G.
Wanders, R. J. A.
Reddy, J. K.
Cherkaoui-Malki, Mustapha
The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title_full The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title_fullStr The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title_full_unstemmed The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title_short The Inflammatory Response in Acyl-CoA Oxidase 1 Deficiency (Pseudoneonatal Adrenoleukodystrophy)
title_sort inflammatory response in acyl-coa oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy)
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791418/
https://www.ncbi.nlm.nih.gov/pubmed/22508517
http://dx.doi.org/10.1210/en.2012-1137
work_keys_str_mv AT elhajjhi theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT vluggensa theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT andreolettip theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT ragotk theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT mandards theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT kerstens theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT waterhamhr theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT lizardg theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT wandersrja theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT reddyjk theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT cherkaouimalkimustapha theinflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT elhajjhi inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT vluggensa inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT andreolettip inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT ragotk inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT mandards inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT kerstens inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT waterhamhr inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT lizardg inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT wandersrja inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT reddyjk inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy
AT cherkaouimalkimustapha inflammatoryresponseinacylcoaoxidase1deficiencypseudoneonataladrenoleukodystrophy